1: (ROOT (NP (NP (JJ Gut) (NN microbiota)) (CC and) (: Covi-19-) (NP (JJ possible) (NN link) (CC and) (NNS implications)) (. .)))
2: (ROOT (S (NP (CD Covi-19)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ major) (NN pandemic)) (VBG facing) (NP (DT the) (NN world)) (NP (NN today))) (VP (VBN caused) (PP (IN by) (NP (NP (NNP SAR) (HYPH -) (CD Co-2)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (NP (NNS implications)) (PP (IN on) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (JJ infectious) (NNS diseases)))))))))))))) (. .)))
3: (ROOT (S (SBAR (IN Although) (, ,) (S (NP (NNP SAR) (HYPH -) (CD Co-2)) (ADVP (RB primarily)) (VP (VBZ causes) (NP (NN lung) (NN infection)) (PP (IN through) (NP (NP (NN binding)) (PP (IN of) (NP (NP (CD ACE2) (NNS receptors)) (ADJP (JJ present) (PP (IN on) (NP (DT the) (JJ alveolar) (JJ epithelial) (NNS cells))))))))))) (, ,) (RB yet) (S (NP (PRP it)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN reported) (SBAR (IN that) (S (NP (NML (NNP SAR) (HYPH -) (HYPH Co-2)) (NN RNA)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NNS faeces)) (PP (IN of) (NP (JJ infected) (NNS patients)))))))))))) (. .)))
4: (ROOT (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NP (DT the) (JJ intestinal) (JJ epithelial) (NNS cells)) (ADVP (RB particularly)) (DT the) (NNS enterocytes)) (PP (IN of) (NP (DT the) (JJ small) (NN intestine)))) (ADVP (RB also)) (VP (VBP express) (NP (CD ACE2) (NNS receptors))) (. .)))
5: (ROOT (S (NP (NP (NN Role)) (PP (IN of) (NP (DT the) (NN gut) (NN microbiota))) (PP (IN in) (S (VP (VBG influencing) (NP (NN lung) (NNS diseases)))))) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB well)) (VBN articulated)))) (. .)))
6: (ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN known) (SBAR (IN that) (S (NP (NML (JJ respiratory) (NN virus)) (NN infection)) (VP (VBZ causes) (NP (NP (NNS perturbations)) (PP (IN in) (NP (DT the) (NN gut) (NN microbiota))))))))) (. .)))
7: (ROOT (S (NP (NN Diet) (, ,) (NP (JJ environmental) (NNS factors)) (CC and) (NP (NNS genetics))) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (S (VP (VBG shaping) (NP (NP (NN gut) (NNS microbiota)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB influence) (NP (NN immunity))))))))))) (. .)))
8: (ROOT (S (S (NP (NML (NN Gut) (NN microbiota)) (NN diversity)) (VP (VBZ is) (VP (VBN decreased) (PP (IN in) (NP (JJ old) (NN age)))))) (CC and) (S (S (NP (CD Covi-19)) (VP (VBZ has) (VP (VBN been) (ADJP (RB mainly) (JJ fatal)) (PP (IN in) (NP (JJ elderly) (NNS patients)))))) (SBAR (WHNP (WDT which)) (S (ADVP (RB again)) (VP (VBZ points) (PP (IN to) (NP (NP (DT the) (NN role)) (SBAR (S (NP (DT the) (NN gut) (NN microbiota)) (VP (MD may) (VP (VB play) (PP (IN in) (NP (DT this) (NN disease))))))))))))) (. .)))
9: (ROOT (S (S (VP (VBG Improving) (NP (NML (NN gut) (NN microbiota)) (NN profile)) (PP (IN by) (NP (NP (JJ personalized) (NN nutrition) (CC and) (NN supplementation)) (VP (VBN known) (S (VP (TO to) (VP (VB improve) (NP (NN immunity)))))))))) (VP (MD can) (VP (VB be) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ prophylactic) (NNS ways)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (DT this) (NN disease)))) (VP (MD can) (VP (VB be) (VP (VBN minimized) (PP (IN in) (NP (NP (JJ old) (NNS people)) (CC and) (NP (ADJP (NN immun) (HYPH -) (VBN compromised)) (NNS patients)))))))))))))) (. .)))
10: (ROOT (S (NP (JJR More) (NNS trials)) (VP (MD may) (VP (VB be) (VP (VBN initiated) (S (VP (TO to) (VP (VB see) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NN c) (HYPH -) (NN supplementation)) (PP (IN of) (NP (NP (JJ personalized) (JJ functional) (NN food)) (PP (VBG including) (NP (NN prebiotic) (SYM /) (NNS probiotics))))) (PP (IN along) (PP (IN with) (NP (JJ current) (NNS therapies))))))))))))) (. .)))
